The present invention provides the compounds of formula (I):
The present invention relates to imidazo[4,5-c]quinoline derivatives of formula (I), process for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases mediated by phosphatidylinositol-3-kinase (PBK) and/or mammalian target of rapamycin (mTOR) and/or tumor necrosis factor-α (TNF-oc) and/or interleukin-6 (IL-6), particularly in the treatment of cancer and inflammation.
本发明提供了式(I)的化合物:本发明涉及式(I)的
咪唑并[4,5-c]
喹啉衍
生物,其制备方法,含有它们的制药组合物以及它们在治疗由
磷脂酰肌醇-3-激酶(PBK)和/或哺乳动物
雷帕霉素靶
蛋白酶(mTOR)和/或肿瘤坏死因子-α(TNF-oc)和/或白细胞介素-6(IL-6)介导的疾病中的用途,特别是在癌症和炎症的治疗中。